During establishment of a prostate cancer model in rats transgenic for the Simian virus 40 large T antigen, under control of the probasin gene promoter, with protein expression specific to the prostate, tongue, and spinal cord, undifferentiated small round cell tumors were frequently observed. Extensive examination of tongues of the transgenic rats, despite a macroscopically normal appearance, revealed the tumors to have come from taste buds of the papilla circumvallata and papilla foliata. The lesions were positive for the SV40 T antigen, PGP9.5 (ubiquitin C-terminal hydrolase), and synaptophysin, neuron and neuroendocrine markers. Morphologically and immunohistochemically, the tumors were diagnosed as neuroblastomas, considering the neuroepithelial origin. Histologically identical tumor cells in the spinal cord and lung were observed only in the rats with deeply invading tongue tumors, suggesting that metastasis from the tongue tumors had occurred. Castration or supplementation with testosterone propionate did not alter tumor development, indicating the tumors to be androgen-independent . These results clearly show that taste buds can give rise to metastasizing neuroblastomas.
Adams JM, Cory S. ( 1991). Transgenic models of tumor development. Science254: 1161—1167.
2.
Asamoto M., Ochiya T., Toriyama-Baba H., Ota T., Sekiya T., Terada M., Tsuda H. (2000). Transgenic rats carrying human c-Ha-ras proto-oncogene s are highly susceptibletoN-methyl-N-nitrosoure a mammary carcinogenesis. Carcinogenesis21: 243—249.
3.
Bosland MC (1999). Use of animal models in defining efficacy of chemoprevention agents against prostate cancer. Eur Urol35: 459—463.
Cui L., Mori T., Takahashi S., Imaida K., Akagi K., Yada H., Yaono M., Shirai T. (1998). Slight promotion effects of intermittent administration of testosterone propionate and/or diethylstilbestrol on 3,2'-dimethyl-4 -aminobiphenyl-initiate drat prostate carcinogenesis. Cancer Lett122: 195— 199.
6.
DeCaprio JA, Ludlow JW, Figge J., Shew JY, Huang CM, Lee WH, Marsilio E., Paucha E., Livingston DM (1988). SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell54: 275—283.
7.
Dodd JG, Sheppard PC, Matusik RJ (1983). Characterization and cloning of rat dorsal prostate mRNAs. Androgen regulation of two closely related abundant mRNAs. J Biol Chem258: 10731—10737.
8.
Ermisch B., Schwechheimer K. (1995). Protein gene product (PGP). 9.5 in diagnostic (neuro-) oncology. An immunomorphological study. Clin Neuropathol14: 130—136.
9.
Greenberg NM , DeMayo F., Finegold MJ, Medina D., Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM (1995). Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA92: 3439—3443.
10.
Greenberg NM , DeMayo FJ, Sheppard PC, Barrios R., Lebovitz R., Finegold M., Angelopoulou R., Dodd JG, Duckworth ML, Rosen JM, Matusik RJ (1994). The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol8: 230— 239.
11.
Hully JR, Su Y., Lohse JK, Griep AE, Sattler CA, Haas MJ, Dragan Y., Peterson J., Neveu M., Pitot HC (1994). Transgenic hepatocarcinogenesi s in the rat. Am J Pathol145: 386—397.
12.
Hull MT, Eble JN, Warfel KA (1984). Extrapulmonary oat-cell carcinoma of the tongue: An electron-microscopic study. J Oral Pathol13: 489—496.
13.
Kanazawa H. , Yoshie S. (1996). The taste bud and its innervation in the rat as studied by immunohistochemistry for PGP 9.5. Arch Histol Cytol59: 357—367.
14.
Kawabe M., Shibata MA, Sano M., Takesada Y., Tamano S., Ito N., Shirai T. (1997). Decrease of prostaglandin E2 and 5-bromo-2'-deoxyuridine labeling but not prostate tumor development by indomethacin treatment of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate. Jpn J Cancer Res88: 350—355.
15.
Lane DP, Crawford LV (1979). T antigen is bound to a host protein in SV40-transformed cells. Nature278: 261—263.
16.
Linzer DI, Levine AJ (1979). Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell17: 43—52.
17.
McCormick DL , Rao KV, Steele VE, Lubet RA, Kelloff GJ, Bosland MC (1999). Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. Cancer Res59: 521—524.
18.
Mitchell RB , Stedeford J., Buchanan G. (1998). Oat cell carcinoma of the tongue from an unknown primary. Ear Nose Throat J77: 221— 223.
19.
Miyata E., Kawabe M., Sano M., Takesada Y., Takahashi S., Shirai T. (1997). Effects of tamoxifen, an antiestrogen, on rat prostate carcinogenesis by 3,2'-dimethyl-4-aminobiphenyl and testosterone do not support an estrogen role in testosterone promotion. Prostate31: 9—13.
20.
Pallas DC, Shahrik LK, Martin BL, Jaspers S., Miller TB, Brautigan DL, Roberts TM (1990). Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatas e 2A. Cell60: 167— 176.
21.
Rennie PS, Bruchovsky N., Leco KJ, Sheppard PC, McQueen SA, Cheng H., Snoek R., Hamel A., Bock ME, MacDonald BS (1993). Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol7: 23—36.
22.
Sharma P., Schreiber-Agus N. (1999). Mouse models of prostate cancer. Oncogene18: 5349—5355.
23.
Shibata MA, Ward JM, Devor DE, Liu ML, Green JE (1996). Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations. Cancer Res56: 4894—4903.
24.
Shirai T., Imaida K., Masui T., Iwasaki S., Mori T., Kato T., Ito N. (1994). Effects of testosterone, dihydrotestosterone and estrogen on 3,2'-dimethyl4-aminobiphenyl-induce drat prostate carcinogenesis. IntJ Cancer57:224— 228.
25.
Shirai T., Takahashi S., Cui L., Futakuchi M., Kato K., Tamano S., Imaida K. (2000). Experimental prostate carcinogenesis—rodent models. Mutat Res462: 219—226.
26.
Tsukamoto S. , Akaza H., Onozawa M., Shirai T., Ideyama Y. (1998). A fivealpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats. Cancer82: 531—537.
27.
Wiedenmann B., Kuhn C., Schwechheimer K., Waldherr R., Raue F., Brandeis WE, Kommerell B., Franke WW (1987). Synaptophysin identified in metastases of neuroendocrine tumors by immunocytochemistry and immunoblotting . Am J Clin Pathol88: 560—569.
